Download citation file:
From McMaster University, Hamilton, Ontario, Canada; Karolinska University Hospital, Stockholm, Sweden; Arcispedale Santa Maria Nuova, Reggio Emilia, Italy; and University of Padua, Padua, Italy.
Acknowledgment: The authors thank Drs. Jeffrey S. Ginsberg, Frederick A. Spencer, and Richard H. White for their helpful reviews of this manuscript.
Potential Financial Conflicts of Interest: None disclosed.
Requests for Single Reprints: James D. Douketis, MD, St. Joseph's Healthcare, Room F-544, 50 Charlton Avenue East, Hamilton, Ontario, Canada, L8N 4A6; e-mail, email@example.com.
Current Author Addresses: Dr. Douketis: St. Joseph's Healthcare, Room F-544, 50 Charlton Avenue East, Hamilton, Ontario L8N 4A6, Canada.
Mr. Gu: Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario L8V 1C3, Canada.
Dr. Schulman: Department of Hematology, Karolinska University Hospital, Stockholm, Sweden.
Dr. Ghirarduzzi: Department of Internal Medicine, Angiology Unit, Arcispedale Santa Maria Nuova, Reggio Emilia, Italy.
Dr. Pengo: Department of Cardiothoracic and Vascular Sciences, University of Padua, Padua, Italy.
Dr. Prandoni: Department of Medical and Surgical Sciences, Thromboembolism Unit, University of Padua, Padua, Italy.
Author Contributions: Conception and design: J.D. Douketis, S. Schulman, P. Prandoni.
Analysis and interpretation of the data: J.D. Douketis, C.S. Gu, S. Schulman, A. Ghirarduzzi, V. Pengo, P. Prandoni.
Drafting of the article: J.D. Douketis, C.S. Gu.
Critical revision of the article for important intellectual content: J.D. Douketis, S. Schulman, P. Prandoni.
Final approval of the article: J.D. Douketis, C.S. Gu, S. Schulman, A. Ghirarduzzi, V. Pengo, P. Prandoni.
Provision of study materials or patients: S. Schulman, A. Ghirarduzzi, V. Pengo, P. Prandoni.
Statistical expertise: C.S. Gu.
Collection and assembly of data: S. Schulman, A. Ghirarduzzi, V. Pengo, P. Prandoni.
We aimed to provide reliable and precise estimates of the annual risk for fatal PE and the case-fatality rate of recurrent disease after discontinuation of anticoagulant therapy for a first episode of symptomatic VTE. Our data are based on an inception cohort of more than 2000 patients who were followed, on average, for 4.5 years after discontinuing anticoagulant therapy. We found that the risk for death from PE after stopping anticoagulation is 0.19 to 0.49 events per 100 person-years and the case-fatality rate of recurrent VTE is 4% to 9%. The lower bounds of these estimates correspond to a rigorous definition of fatal PE. The upper bound includes difficult-to-confirm cases of possible fatal PE.
DVT = deep venous thrombosis.
Please read the other comments before posting. Contributors must reveal any conflict
Comments are moderated and will appear on the site at the discretion of The American
College of Physicians editorial staff. Please be sure your email address is
updated in your account, otherwise the American College of Physicians will not be
able to contact you about your comment.
Anyone can submit a comment any time after publication, but only those submitted within 4 weeks of an article’s publication will be considered for print publication. One month after publication, editors review all posted comments and select some for publication in the Letters section of the print version of Annals. (Not peer reviewed)
Authors: No more than 5
Text: Word Limit 400 (excludes references), 5 references, no figures or tables
* = Required Field
Disclosure of Any Conflicts of Interest*
(applies to the past 5 years and foreseeable future) Indicate any potential conflicts
of interest of each author below, including specific financial interests and relationships
and affiliations relevant to the subject matter or materials discussed in the manuscript
(eg, employment/affiliation, grants or funding, consultancies, honoraria, speakers
bureau, stock ownership or options, expert testimony, royalties, donation of medical
equipment, or patents filed, received, or pending). If all authors have none, check
"No potential conflicts or relevant financial interests" in the box below. Please
also indicate any funding received in support of this work. The information will
be posted with your response.
Risk for Fatal Pulmonary Embolism after Discontinuing Anticoagulation
The summary below is from the full report titled “The Risk for Fatal Pulmonary Embolism after Discontinuing Anticoagulant Therapy for Venous Thromboembolism.” It is in the 4 December 2007 issue of Annals of Internal Medicine (volume 147, pages 766-774). The authors are J.D. Douketis, C.S. Gu, S. Schulman, A. Ghirarduzzi, V. Pengo, and P. Prandoni.
The In the Clinic® slide sets are owned and copyrighted by the American College
of Physicians (ACP). All text, graphics, trademarks, and other intellectual property
incorporated into the slide sets remain the sole and exclusive property of the ACP.
The slide sets may be used only by the person who downloads or purchases them and
only for the purpose of presenting them during not-for-profit educational activities.
Users may incorporate the entire slide set or selected individual slides into their
own teaching presentations but may not alter the content of the slides in any way
or remove the ACP copyright notice. Users may make print copies for use as hand-outs
for the audience the user is personally addressing but may not otherwise reproduce
or distribute the slides by any means or media, including but not limited to sending
them as e-mail attachments, posting them on Internet or Intranet sites, publishing
them in meeting proceedings, or making them available for sale or distribution in
any unauthorized form, without the express written permission of the ACP. Unauthorized
use of the In the Clinic slide sets will constitute copyright infringement.
to gain full access to the content and tools.
Learn more about subscription options